News
Except when we fly, or see rockets and missiles, we mostly ignore the air we breathe. But when the air becomes poisoned with ...
“This biosensor is the first of its kind,” said Rajan Chakrabarty, a professor of energy, environmental, and chemical ...
Researchers at Washington University in Saint Louis have developed a biosensor that can detect airborne H5N1 avian influenza ...
An AI-driven platform has been used to optimize an antibody, 3152-1142, to neutralize a wide range of SARS-CoV-2 variants, enhancing its potency against potential escape mutations.
Background Infectious agents such as SARS-CoV-2 require strategies to contain outbreaks, particularly in hospitals where the spread of infection is most likely. Biometric monitoring of heart rate, ...
The gene encoding an enzyme from a firefly, discovered at the Sorocaba campus of the Federal University of São Carlos (UFSCar) in Brazil, has given ...
Hultquist. After proving its efficacy in testing for both the SARS-CoV-2 virus that causes COVID-19, and now HIV, the team is confident that the biosensor will continue to prove effective when testing ...
Here, we elucidated the differential antiviral and immunoregulatory roles of SP-A variants in response to SARS-CoV-2 infection in vivo. Methods: Six genetically-modified mouse lines, expressing both ...
Similarly, patients who tested positive for COVID-19 who were not admitted to hospital had higher rates in 32% of the laboratory-based outcomes compared to those who tested negative for SARS-CoV-2.
Ensitrelvir was effective as post-exposure prophylaxis against COVID-19 if taken within 72 hours of exposure to SARS-CoV-2. The drug was granted fast-track designation by the FDA earlier this year.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of the ongoing global pandemic, has constituted the worst global health disaster in recent years. However, no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results